regulatory
confidence high
sentiment negative
materiality 0.60
XWELL receives Nasdaq bid price deficiency notice; cure period through June 2026
XWELL, Inc.
- Closing bid price below $1.00 for 30 consecutive business days ended Nov 28, 2025.
- Compliance period of 180 days, ending June 1, 2026, to regain $1.00 minimum bid.
- Must maintain $1.00 closing bid for 10 consecutive days to cure deficiency.
- If not cured, may qualify for additional 180 days by meeting other listing standards.
- No immediate impact on trading; stock continues on Nasdaq during cure period.